Loading
IARC estimates 13,942 new cancer cases and 9,026 cancer deaths in Mali in 2024; the commonest new cancers are breast, cervix uteri and stomach. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 2,554 | 38.8 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 2,042 | 34.7 | Cervical cancer |
| Stomach | 1,050 | 10.5 | Gastric & gastro-oesophageal junction cancer |
| Colorectum | 899 | 7.9 | Colorectal cancer |
| Liver and intrahepatic bile ducts | 665 | 5.6 | Hepatocellular carcinoma |
| Bladder | 616 | 5.7 | Bladder & urothelial cancer |
| Prostate | 582 | 16.2 | Prostate cancer |
| Trachea, bronchus and lung | 373 | 3.9 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Non-Hodgkin lymphoma | 346 | 1.9 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Thyroid | 310 | 2.8 | Thyroid cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 1,242 | 21.6 | Cervical cancer |
| Breast | 1,217 | 19.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Stomach | 863 | 9.0 | Gastric & gastro-oesophageal junction cancer |
| Liver and intrahepatic bile ducts | 593 | 5.1 | Hepatocellular carcinoma |
| Colorectum | 480 | 4.5 | Colorectal cancer |
| Prostate | 355 | 10.0 | Prostate cancer |
| Bladder | 354 | 3.6 | Bladder & urothelial cancer |
| Trachea, bronchus and lung | 339 | 3.6 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Brain, central nervous system | 241 | 1.7 | Glioma & glioblastoma |
| Pancreas | 229 | 2.3 | Pancreatic ductal adenocarcinoma |
No trial record in OnCo lists a site in Mali. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Mali.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Mali is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Mali is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.